SCHEMBL1204147

SCHEMBL1204147

O=C(O)CCCCCCCCCCCCCCCCC(=O)NCO

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.57
LMNA P02545 2/20 0.57
NFKB1 P19838 1/20 0.57
PMP22 Q01453 1/20 0.57
GPR84 Q9NQS5 4/20 0.54
FFAR1 O14842 2/20 0.54
FFAR4 Q5NUL3 2/20 0.54
PRMT1 Q99873 1/20 0.52
EPHX2 P34913 2/20 0.51
PTPN1 P18031 2/20 0.50
ADRA1A P35348 1/20 0.48
KDM4E B2RXH2 1/20 0.47
ABCC4 O15439 1/20 0.46
MAPT P10636 1/20 0.46
PPARG P37231 4/20 0.46
PPARD Q03181 4/20 0.46
PPARA Q07869 4/20 0.46
HDAC11 Q96DB2 3/20 0.46
ALDH1A1 P00352 2/20 0.46
TDP1 Q9NUW8 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20651630 1.00 TSHR (0.57) TSHRLMNANFKB1PMP22GPR84
SCHEMBL10340097 0.93 SLC22A6 (0.55) TSHRLMNANFKB1PMP22GPR84
SCHEMBL4357532 0.90 HDAC3 (0.52) TSHRPTPN1MAPTALDH1A1TDP1
SCHEMBL13241887 0.87 RECQL (0.54) TSHRPTPN1MAPTALDH1A1TDP1
SCHEMBL24961509 0.86 PTPN1 (0.59) TSHRLMNANFKB1PMP22GPR84
SCHEMBL20750809 0.86 PTPN1 (0.59) TSHRLMNANFKB1PMP22GPR84
SCHEMBL2808624 0.86 PTPN1 (0.59) TSHRLMNANFKB1PMP22GPR84
SCHEMBL22838868 0.86 PTPN1 (0.59) TSHRLMNANFKB1PMP22GPR84
SCHEMBL13694070 0.86 PTPN1 (0.59) TSHRLMNANFKB1PMP22GPR84
SCHEMBL12296709 0.86 PTPN1 (0.59) TSHRLMNANFKB1PMP22GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019034726-A1 NOVEL ACYLATED INSULIN ANALOGUES AND USES THEREOF NOVO NORDISK A/S (DK) 2019-02-21 WO disclosed
EP-2291426-A1 ADDUCTS OF EPOXY RESINS DERIVED FROM ALKANOLAMIDES AND A PROCESS FOR PREPARING THE SAME Dow Global Technologies Inc. (US) 2011-03-09 EP disclosed
US-20110046321-A1 ADDUCTS OF EPOXY RESINS DERIVED FROM ALKANOLAMIDES AND A PROCESS FOR PREPARING THE SAME DOW GLOBAL TECHNOLOGIES LLC 2011-02-24 US disclosed
WO-2009143038-A1 ADDUCTS OF EPOXY RESINS DERIVED FROM ALKANOLAMIDES AND A PROCESS FOR PREPARING THE SAME DOW GLOBAL TECHNOLOGIES INC. (US) 2009-11-26 WO disclosed
EP-1778732-B1 PARTIALLY-SOLUBLE CROSS-LINKED STARCH AND FILM-FORMING COMPOSITION CONTAINING the SAME ROQUETTE FRERES (FR) 2008-11-19 EP disclosed
US-20060141146-A1 Heat-sensitive adhesive material KUGO TOMOYUKI 2006-06-29 US disclosed
US-7056552-B2 Mixing containing solid plasticizer; depression of melting point RICOH COMPANY, LTD. (JP) 2006-06-06 US disclosed
EP-1396528-B1 Heat-sensitive adhesive material RICOH KK (JP) 2005-11-02 EP disclosed
EP-1396528-A1 Heat-sensitive adhesive material Ricoh Company, Ltd. (JP) 2004-03-10 EP disclosed
US-20040043236-A1 Heat-sensitive adhesive material RICOH COMPANY, LTD. (JP) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046321-A1 ADDUCTS OF EPOXY RESINS DERIVED FROM ALKANOLAMIDES AND A PROCESS FOR PREPARING THE SAME ALKBH2, GNE, ALKBH3 TSHR 4846/4885LMNA 72/4885NFKB1 3601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.